Isodiol International Inc. Completes Acquisition of Farmtiva Inc. for 51% Ownership and Completes First Planting of Farm Bill Compliant Hemp in California Cannabis Investing News
Clovis Oncology Submits Application to EMA to Expand Use of Rubraca (rucaparib) to Include Maintenance Treatment for Women with Recurrent Ovarian Cancer Biotech Investing
Mersana Presents Interim Dose-Escalation Data on XMT-1522 in Select Cancers at ASCO 2018 Biotech Investing
CytomX Therapeutics Presents Preliminary Clinical Proof-of-Concept Data from Probody™ Platform and CX-072 at 2018 ASCO Annual Meeting Biotech Investing
New Data from Phase 1 Study of Ivosidenib or Enasidenib in Combination with Azacitidine Demonstrate Robust Responses Biotech Investing
Exelixis Announces Further Expansion to Clinical Research Protocol for Phase 1b COSMIC-021 Trial of Cabozantinib in Combination with Anti-PD-L1 Immunotherapy in Patients with Locally Advanced or Metastatic Solid Tumors Biotech Investing
SELLAS Life Sciences Provides Clinical Update on Phase 2b NeuVax™ (nelipepimut-S) Study in Combination with Trastuzumab in HER2 1+/2+ Breast Cancer Patients Pharmaceutical Investing
Immunomedics Announces Pivotal Study of Sacituzumab Govitecan in Patients With Locally Advanced or Metastatic Urothelial Cancer Pharmaceutical Investing
MYALEPTA (metreleptin) Receives Positive CHMP Opinion in Patients with Generalized and Partial Lipodystrophy Pharmaceutical Investing
Sarepta Receives Negative CHMP Opinion for EXONDYS® (eteplirsen) to Treat Patients with Duchenne Muscular Dystrophy in Europe Pharmaceutical Investing
